New Step by Step Map For Mouse
All enrolled sufferers who been given no less than one dose of zosuquidar or placebo all through induction had been monitored for that prevalence of adverse events (439 individuals, 219 on zosuquidar and 210 on placebo). The most typical adverse gatherings were being associated with the period of prolonged and considerable myelosuppression as is ex